Semprana

Allergan says U.S. FDA sent 2nd letter on acute migraine treatment
Yahoo/Reuters
Mon, 06/30/14 - 08:55 am
FDA
Allergan
migraines
Semprana
Levadex
Valeant Pharmaceuticals